previously reported the presence of EREs in the EZH2 promoter region (22) and that we found two others potential EREs through an in silico analysis, we decided to evaluate whether E2 (10 nM) treatments also regulate EZH2 expression in GBM cell lines. The gene discussed is EZH2; the disease is glioblastoma.